Vaqta 50 Unit (Hepatitis a Vaccine, Inactivated SUSPENSION) 50 UNIT

VAQTA 50 Unit is a hepatitis A vaccine designed to prevent hepatitis A virus infection. This inactivated vaccine is administered intramuscularly and is suitable for individuals at risk of exposure.

Strength

50 UNIT

Pack Size

0.5ML/1ML

Manufacturer / TM Owner

MERCK CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

VAQTA 50 Unit is used to protect against hepatitis A, a viral infection that affects the liver. This vaccine is typically recommended for travelers to areas with high rates of hepatitis A, as well as for individuals with certain medical conditions or lifestyles that increase their risk of exposure. The vaccine works by stimulating the body's immune system to produce antibodies against the hepatitis A virus.

Side Effects

Common effects of VAQTA 50 Unit may include soreness, redness, or swelling at the injection site. Some individuals may experience mild fever, headache, or fatigue following vaccination. These effects are usually temporary and resolve on their own within a few days.

Precautions & Warnings

VAQTA 50 Unit should be stored and handled according to the manufacturer's guidelines to maintain its effectiveness. Individuals with a history of severe allergic reactions to any component of the vaccine should consult a healthcare provider before receiving it. It is important to inform your healthcare provider about any medical conditions or medications you are taking before vaccination.

Avoid Interactions

VAQTA 50 Unit may interact with certain medications or other vaccines. It is advisable to discuss any ongoing treatments or recent vaccinations with a healthcare provider to ensure safe administration. Avoid alcohol consumption immediately after vaccination, as it may affect the immune response.

Frequently Asked Questions

VAQTA 50 Unit is used to prevent hepatitis A virus infection, particularly in individuals at risk due to travel or medical conditions.

VAQTA 50 Unit is administered intramuscularly, typically in the upper arm.

Common side effects include soreness, redness, or swelling at the injection site, as well as mild fever, headache, or fatigue.

Individuals with a history of severe allergic reactions to any component of the vaccine should consult a healthcare provider before receiving VAQTA 50 Unit.

It is important to discuss any ongoing treatments or recent vaccinations with a healthcare provider to ensure safe administration of VAQTA 50 Unit.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.